Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ADAPYADAPY
Showing 6 of 10 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

WELLS FARGO & COMPANY/MN previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$63,507

Total Shares Change

-66,821

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.03
0
2025-Q3
Decreased
2,700
-94.5%
$3510.0%$0.14
0
2025-Q2
Increased
48,900
+20.1%
$11,7210.0%$0.25
14
2025-Q1
Decreased
40,700
-36.4%
$8,0180.0%$0.21
0
2024-Q4
Decreased
63,967
-4.3%
$34,4590.0%$0.55
0
2024-Q3
Increased
66,821
+5.0%
$63,5070.0%$0.98
15

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used